Fortress Biotech, Inc. (FBIO) vs Heron Therapeutics, Inc. (HRTX)

A side-by-side comparison of Fortress Biotech, Inc. and Heron Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — FBIO vs HRTX

growth of $100 · dividends reinvested · last 10y
FBIO -95.1% (-26.1%/yr)HRTX -97.7% (-31.4%/yr)FBIO compounded faster over this window
050100150200250Start $10020182020202220242026$5$2
FBIO HRTX

FBIO vs HRTX: by the numbers

  • •FBIO is the larger company ($68M vs $65M market cap).
  • •FBIO is profitable (163.32% net margin) while HRTX runs a net loss (-22.52%).
  • •HRTX grew revenue faster over the past five years (12.73% vs 5.39% CAGR).

Metrics side by side

Valuation

MetricFBIOHRTX
P/E ratio0.76N/A
P/S ratio0.990.43
P/B ratio0.4111.09
FCF yield186.15%N/A

Profitability

MetricFBIOHRTX
Gross margin62.53%70.07%
Operating margin-111.00%-7.19%
Net margin163.32%-22.52%
ROE68.12%-492.89%
ROIC-10.85%-6.79%

Growth (annualized)

MetricFBIOHRTX
Revenue CAGR (5Y)5.39%12.73%
Total return CAGR (5Y)-46.06%-48.61%

Frequently asked

Which has grown faster, FBIO or HRTX?
Over the past five years, HRTX grew revenue faster — FBIO at a 5.39% CAGR versus HRTX at 12.73%.
Is FBIO or HRTX more profitable?
FBIO runs the higher net margin — FBIO at 163.32% versus HRTX at -22.52%.
How have FBIO and HRTX total returns compared?
Over the past 10 years, FBIO delivered -26.29% and HRTX delivered -31.88% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.